久光製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2024/10/25 | 4,287 | 4,299 | 4,252 | 4,283 | -16 | -0.4% | 141,100 |
| 2024/10/24 | 4,323 | 4,359 | 4,290 | 4,299 | -47 | -1.1% | 184,100 |
| 2024/10/23 | 4,334 | 4,385 | 4,300 | 4,346 | +43 | +1% | 203,600 |
| 2024/10/22 | 4,300 | 4,333 | 4,293 | 4,303 | +4 | +0.1% | 158,300 |
| 2024/10/21 | 4,280 | 4,306 | 4,240 | 4,299 | +8 | +0.2% | 153,400 |
| 2024/10/18 | 4,320 | 4,364 | 4,251 | 4,291 | +4 | +0.1% | 236,400 |
| 2024/10/17 | 4,076 | 4,298 | 4,076 | 4,287 | +211 | +5.2% | 315,900 |
| 2024/10/16 | 4,050 | 4,154 | 4,050 | 4,076 | -7 | -0.2% | 128,500 |
| 2024/10/15 | 4,080 | 4,139 | 4,033 | 4,083 | +45 | +1.1% | 143,900 |
| 2024/10/11 | 4,095 | 4,198 | 4,025 | 4,038 | -12 | -0.3% | 334,800 |
| 2024/10/10 | 4,005 | 4,062 | 3,982 | 4,050 | +24 | +0.6% | 94,700 |
| 2024/10/09 | 4,045 | 4,098 | 4,007 | 4,026 | +1 | ±0% | 126,500 |
| 2024/10/08 | 3,960 | 4,026 | 3,957 | 4,025 | +24 | +0.6% | 121,300 |
| 2024/10/07 | 4,020 | 4,031 | 3,985 | 4,001 | -6 | -0.1% | 127,300 |
| 2024/10/04 | 3,947 | 4,027 | 3,938 | 4,007 | +57 | +1.4% | 127,400 |
| 2024/10/03 | 3,954 | 3,966 | 3,928 | 3,950 | +50 | +1.3% | 126,800 |
| 2024/10/02 | 3,865 | 3,910 | 3,864 | 3,900 | +13 | +0.3% | 119,900 |
| 2024/10/01 | 3,863 | 3,898 | 3,852 | 3,887 | +24 | +0.6% | 74,200 |
| 2024/09/30 | 3,871 | 3,897 | 3,851 | 3,863 | -97 | -2.4% | 89,900 |
| 2024/09/27 | 3,991 | 4,015 | 3,958 | 3,960 | -51 | -1.3% | 79,800 |
| 2024/09/26 | 3,935 | 4,011 | 3,929 | 4,011 | +82 | +2.1% | 136,500 |
| 2024/09/25 | 3,903 | 3,956 | 3,892 | 3,929 | +26 | +0.7% | 76,100 |
| 2024/09/24 | 3,928 | 3,928 | 3,893 | 3,903 | -25 | -0.6% | 92,700 |
| 2024/09/20 | 3,955 | 3,992 | 3,916 | 3,928 | -20 | -0.5% | 208,600 |
| 2024/09/19 | 3,946 | 3,984 | 3,909 | 3,948 | +38 | +1% | 74,400 |
| 2024/09/18 | 3,940 | 3,961 | 3,874 | 3,910 | -29 | -0.7% | 102,800 |
| 2024/09/17 | 3,945 | 3,980 | 3,886 | 3,939 | +14 | +0.4% | 133,300 |
| 2024/09/13 | 3,937 | 3,948 | 3,897 | 3,925 | -44 | -1.1% | 93,000 |
| 2024/09/12 | 3,965 | 4,011 | 3,934 | 3,969 | +14 | +0.4% | 99,600 |
| 2024/09/11 | 4,035 | 4,035 | 3,923 | 3,955 | -85 | -2.1% | 71,300 |
| 2024/09/10 | 4,020 | 4,066 | 4,011 | 4,040 | +3 | +0.1% | 127,400 |
| 2024/09/09 | 3,988 | 4,040 | 3,972 | 4,037 | +43 | +1.1% | 82,300 |
| 2024/09/06 | 4,008 | 4,016 | 3,977 | 3,994 | +3 | +0.1% | 62,200 |
| 2024/09/05 | 4,006 | 4,029 | 3,974 | 3,991 | -15 | -0.4% | 92,400 |
| 2024/09/04 | 3,999 | 4,060 | 3,985 | 4,006 | -60 | -1.5% | 92,600 |
| 2024/09/03 | 4,018 | 4,072 | 4,018 | 4,066 | +66 | +1.7% | 61,400 |
| 2024/09/02 | 4,048 | 4,048 | 3,985 | 4,000 | -58 | -1.4% | 73,500 |
| 2024/08/30 | 4,047 | 4,077 | 4,021 | 4,058 | +11 | +0.3% | 101,500 |
| 2024/08/29 | 4,060 | 4,090 | 4,031 | 4,047 | -79 | -1.9% | 84,300 |
| 2024/08/28 | 4,088 | 4,140 | 4,076 | 4,126 | +23 | +0.6% | 117,200 |
| 2024/08/27 | 4,140 | 4,140 | 4,086 | 4,103 | -18 | -0.4% | 65,800 |
| 2024/08/26 | 4,107 | 4,126 | 4,073 | 4,121 | -19 | -0.5% | 52,300 |
| 2024/08/23 | 4,128 | 4,140 | 4,095 | 4,140 | +26 | +0.6% | 68,500 |
| 2024/08/22 | 4,082 | 4,126 | 4,081 | 4,114 | +44 | +1.1% | 68,800 |
| 2024/08/21 | 4,050 | 4,077 | 4,042 | 4,070 | -8 | -0.2% | 57,400 |
| 2024/08/20 | 4,014 | 4,083 | 4,014 | 4,078 | +65 | +1.6% | 85,000 |
| 2024/08/19 | 4,000 | 4,045 | 3,992 | 4,013 | -24 | -0.6% | 58,700 |
| 2024/08/16 | 4,038 | 4,038 | 3,992 | 4,037 | +31 | +0.8% | 92,600 |
| 2024/08/15 | 3,965 | 4,020 | 3,939 | 4,006 | +41 | +1% | 77,100 |
| 2024/08/14 | 3,981 | 3,981 | 3,923 | 3,965 | -10 | -0.3% | 105,500 |
201～
250
件表示中 / 3767件
類似銘柄と比較する
現在ご覧いただいている「久光薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 久光薬 | 428,400円 | +5.8% | +1.2% | 2.80% | 13.87倍 | 1.10倍 |
|
貼る鎮痛消炎剤首位。医療用シェア５割。大衆薬「サロンパス」で有名。米国、中国など海外強化 |
| 住友ファーマ | 140,700円 | -11.0% | +206.6% | 0.00% | 13.97倍 | 3.30倍 |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
| 参天薬 | 156,700円 | -2.0% | -7.3% | 2.43% | 15.32倍 | 1.82倍 |
|
緑内障、加齢黄斑変性、ドライアイ治療薬など眼科用医薬品首位。一般用目薬「サンテ」が有名 |
| ツムラ | 361,300円 | +3.8% | -19.9% | 3.76% | 11.74倍 | 0.90倍 |
|
医療用漢方薬で国内シェア８割超。高齢者、がん支持療法、女性関連の３領域を重点に市場深耕 |
| 日本新薬 | 322,200円 | +3.6% | -15.3% | 3.85% | 9.05倍 | 0.88倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
市場注目の銘柄
チャート関連のコラム
